DE122005000018I1 - Azellulärer Impfstoff. - Google Patents

Azellulärer Impfstoff.

Info

Publication number
DE122005000018I1
DE122005000018I1 DE200512000018 DE122005000018C DE122005000018I1 DE 122005000018 I1 DE122005000018 I1 DE 122005000018I1 DE 200512000018 DE200512000018 DE 200512000018 DE 122005000018 C DE122005000018 C DE 122005000018C DE 122005000018 I1 DE122005000018 I1 DE 122005000018I1
Authority
DE
Germany
Prior art keywords
vaccine
acellular vaccine
antigens
acellular
pertussis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE200512000018
Other languages
English (en)
Inventor
Pavel Novotny
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medeva Holdings BV
Original Assignee
Medeva Holdings BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10656410&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE122005000018(I1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Medeva Holdings BV filed Critical Medeva Holdings BV
Publication of DE122005000018I1 publication Critical patent/DE122005000018I1/de
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/099—Bordetella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
DE200512000018 1989-05-08 1990-04-26 Azellulärer Impfstoff. Pending DE122005000018I1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898910570A GB8910570D0 (en) 1989-05-08 1989-05-08 Acellular vaccine

Publications (1)

Publication Number Publication Date
DE122005000018I1 true DE122005000018I1 (de) 2005-06-23

Family

ID=10656410

Family Applications (14)

Application Number Title Priority Date Filing Date
DE200512000020 Pending DE122005000020I1 (de) 1989-05-08 1990-04-26 Azellulärer Impfstoff.
DE200512000017 Pending DE122005000017I1 (de) 1989-05-08 1990-04-26 Azellulärer Impfstoff.
DE200512000018 Pending DE122005000018I1 (de) 1989-05-08 1990-04-26 Azellulärer Impfstoff.
DE122009000041C Pending DE122009000041I1 (de) 1989-05-08 1990-04-26 Verfahren zur Herstellung eines azellulären Impfstoffes der Bordetella Pertussis Antigene enthält
DE69034264T Expired - Lifetime DE69034264D1 (de) 1989-05-08 1990-04-26 Verfahren zur Herstellung eines azellulären Impfstoffes der Bordetella pertussis Antigene enthält
DE200512000019 Pending DE122005000019I1 (de) 1989-05-08 1990-04-26 Azellulärer Impfstoff.
DE122009000043C Pending DE122009000043I1 (de) 1989-05-08 1990-04-26 Verfahren zur Herstellung eines azellulären Impfstoffes der Bordetella Pertussis Antigene enthält
DE122009000044C Pending DE122009000044I1 (de) 1989-05-08 1990-04-26 Verfahren zur Herstellung eines azellulären Impfstoffes der Bordetella Pertussis Antigene enthält
DE69034166T Expired - Lifetime DE69034166T2 (de) 1989-05-08 1990-04-26 Azellulärer Impfstoff
DE200512000016 Pending DE122005000016I1 (de) 1989-05-08 1990-04-26 Azellulärer Impfstoff.
DE200512000014 Pending DE122005000014I1 (de) 1989-05-08 1990-04-26 Azellulärer Impfstoff.
DE122009000042C Pending DE122009000042I1 (de) 1989-05-08 1990-04-26 Verfahren zur Herstellung eines azellulären Impfstoffes der Bordetella Pertussis Antigene enthält
DE69029656T Expired - Lifetime DE69029656T3 (de) 1989-05-08 1990-04-26 Azellulärer impfstoff
DE200512000015 Pending DE122005000015I1 (de) 1989-05-08 2004-10-28 Azellul{rer Impfstoff.

Family Applications Before (2)

Application Number Title Priority Date Filing Date
DE200512000020 Pending DE122005000020I1 (de) 1989-05-08 1990-04-26 Azellulärer Impfstoff.
DE200512000017 Pending DE122005000017I1 (de) 1989-05-08 1990-04-26 Azellulärer Impfstoff.

Family Applications After (11)

Application Number Title Priority Date Filing Date
DE122009000041C Pending DE122009000041I1 (de) 1989-05-08 1990-04-26 Verfahren zur Herstellung eines azellulären Impfstoffes der Bordetella Pertussis Antigene enthält
DE69034264T Expired - Lifetime DE69034264D1 (de) 1989-05-08 1990-04-26 Verfahren zur Herstellung eines azellulären Impfstoffes der Bordetella pertussis Antigene enthält
DE200512000019 Pending DE122005000019I1 (de) 1989-05-08 1990-04-26 Azellulärer Impfstoff.
DE122009000043C Pending DE122009000043I1 (de) 1989-05-08 1990-04-26 Verfahren zur Herstellung eines azellulären Impfstoffes der Bordetella Pertussis Antigene enthält
DE122009000044C Pending DE122009000044I1 (de) 1989-05-08 1990-04-26 Verfahren zur Herstellung eines azellulären Impfstoffes der Bordetella Pertussis Antigene enthält
DE69034166T Expired - Lifetime DE69034166T2 (de) 1989-05-08 1990-04-26 Azellulärer Impfstoff
DE200512000016 Pending DE122005000016I1 (de) 1989-05-08 1990-04-26 Azellulärer Impfstoff.
DE200512000014 Pending DE122005000014I1 (de) 1989-05-08 1990-04-26 Azellulärer Impfstoff.
DE122009000042C Pending DE122009000042I1 (de) 1989-05-08 1990-04-26 Verfahren zur Herstellung eines azellulären Impfstoffes der Bordetella Pertussis Antigene enthält
DE69029656T Expired - Lifetime DE69029656T3 (de) 1989-05-08 1990-04-26 Azellulärer impfstoff
DE200512000015 Pending DE122005000015I1 (de) 1989-05-08 2004-10-28 Azellul{rer Impfstoff.

Country Status (12)

Country Link
US (1) US7479283B1 (de)
EP (3) EP0747058B1 (de)
JP (2) JP3281369B2 (de)
AT (3) ATE147271T1 (de)
DE (14) DE122005000020I1 (de)
DK (3) DK0471726T4 (de)
ES (3) ES2230555T3 (de)
FR (1) FR09C0033I1 (de)
GB (1) GB8910570D0 (de)
LU (15) LU90204I2 (de)
NL (13) NL980007I1 (de)
WO (1) WO1990013313A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8412207D0 (en) * 1984-05-12 1984-06-20 Wellcome Found Antigenic preparations
GB8910570D0 (en) 1989-05-08 1989-06-21 Wellcome Found Acellular vaccine
EP0484621A3 (en) * 1990-07-11 1992-08-26 American Cyanamid Company Efficacious vaccines against bordetella pertussis comprising a combination of individually purified pertussis antigens
GB9021004D0 (en) * 1990-09-27 1990-11-07 Wellcome Found Acellular vaccines
GB9209118D0 (en) * 1992-04-28 1992-06-10 Sb 120 Amsterdam Bv Vaccine compositions
FR2754543B1 (fr) * 1996-10-11 1998-12-31 Pasteur Institut Souche de bordetella deficiente dans la production de toxine et exprimant une proteine hydride, liposomes comprenant de la fha et leurs utilisations comme vaccins, et utilisation de la fha pour stimuler les reponses immunitaires
US7022522B2 (en) 1998-11-13 2006-04-04 Limin Guan Macroporous polymer scaffold containing calcium phosphate particles
WO2005032584A2 (en) * 2003-10-02 2005-04-14 Glaxosmithkline Biologicals S.A. Pertussis antigens and use thereof in vaccination
US8877201B2 (en) * 2007-10-25 2014-11-04 Wake Forest University Health Sciences Bordetella outer-membrane protein antigens and methods of making and using the same
CN101808966A (zh) 2008-03-07 2010-08-18 阿科玛股份有限公司 用氯-3,3,3-三氟丙烯配制的稳定系统
GB201105981D0 (en) 2011-04-08 2011-05-18 Glaxosmithkline Biolog Sa Novel process
EA030749B1 (ru) 2013-03-08 2018-09-28 Янссен Вэксинс Энд Превеншн Б.В. Бесклеточная противококлюшная вакцина
CA2923129C (en) 2013-09-08 2020-06-09 Pfizer Inc. Neisseria meningitidis compositions and methods thereof
BR112017017460A2 (pt) 2015-02-19 2018-04-10 Pfizer Inc. composições de neisseria meningitidis e métodos das mesmas

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2047886A1 (en) 1969-06-30 1971-03-19 Merieux Inst Non-toxic anti-whooping cough vaccine
DE3176347D1 (en) 1980-06-27 1987-09-17 Ciba Geigy Ag Synergistic agents and method for the selective control of weeds, particularly in cereals and soybeans
JPS5750925A (en) 1980-09-12 1982-03-25 Takeda Chem Ind Ltd Preparation of pertussis toxoid
JPS58222032A (ja) 1982-06-18 1983-12-23 Teijin Ltd 百日咳毒素のサブユニツト蛋白
GB8412207D0 (en) 1984-05-12 1984-06-20 Wellcome Found Antigenic preparations
US5237052A (en) * 1984-05-12 1993-08-17 Burroughs Wellcome Company Antigenic preparations and isolation of such preparations
JPS6176422A (ja) * 1984-09-22 1986-04-18 Chemo Sero Therapeut Res Inst 百日ぜきコンポ−ネントワクチンおよび百日ぜき・ジフテリア・破傷風混合ワクチンの製造方法
FR2590483B1 (fr) 1985-11-22 1988-12-09 Pasteur Institut Antigenes purifies ayant des proprietes vaccinantes contre b. pertussis, moyens notamment adns recombinants pour les produire et compositions de vaccins les contenant
GB8601279D0 (en) * 1986-01-20 1986-02-26 Public Health Lab Service Purification of pertussis antigens
DE3783869D1 (de) * 1986-11-11 1993-03-11 Siemens Ag Flusskompensierter stromwandler.
EP0267998A1 (de) * 1986-11-17 1988-05-25 Institut Pasteur Mittel zur Unterstützung gegen Infektion und Vergiftung von Bordetella
FR2606789B1 (fr) 1986-11-17 1991-05-31 Pasteur Institut Preparations d'adenylate cyclase purifiees, procede d'obtention de ces preparations et leurs applications biologiques
US5358868A (en) * 1987-11-24 1994-10-25 Connaught Laboratories Limited Genetic detoxification of pertussis toxin
GB8807860D0 (en) 1988-04-05 1988-05-05 Connaught Lab Pertussis vaccine
US5101014A (en) * 1989-02-10 1992-03-31 United States Of America Process for the purification of a 69,000 da outer membrane protein of Bordetella pertussis
US5162223A (en) * 1989-02-17 1992-11-10 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Resources Hybridomas and resulting monoclonal antibodies directed against antigens of Bordetella pertussis
GB8910570D0 (en) 1989-05-08 1989-06-21 Wellcome Found Acellular vaccine
US5276142A (en) * 1989-12-11 1994-01-04 American Cyanamid Company Process for purification of a 69000 dalton antigenic protein from Bordetella pertussis
GB9007416D0 (en) 1990-04-02 1990-05-30 Wellcome Found Expression of heterologous protein in yeast
GB9007657D0 (en) 1990-04-04 1990-05-30 Connaught Lab Purification of a pertussis outer membrane protein(omp69)
IT1248735B (it) 1990-06-21 1995-01-26 Sclavo Spa Vaccini acellulari contro la pertosse
EP0484621A3 (en) 1990-07-11 1992-08-26 American Cyanamid Company Efficacious vaccines against bordetella pertussis comprising a combination of individually purified pertussis antigens
CN1147259A (zh) 1994-04-28 1997-04-09 武田药品工业株式会社 分离百日咳杆菌保护性组分的方法
US5972225A (en) * 1996-05-07 1999-10-26 Cook Imaging Corporation Process for remediating endotoxin-contaminated bulk non-ionic contrast media

Also Published As

Publication number Publication date
LU91153I2 (fr) 2005-06-23
LU91595I2 (fr) 2009-10-12
EP0747058B1 (de) 2004-09-22
ES2095874T3 (es) 1997-03-01
DK0471726T4 (da) 2008-09-15
NL300404I1 (en) 2009-10-01
NL300187I1 (nl) 2005-06-01
NL300401I1 (en) 2009-10-01
LU91593I2 (fr) 2009-10-12
NL300188I1 (nl) 2005-06-01
NL300183I1 (nl) 2005-06-01
EP1666057A2 (de) 2006-06-07
ES2322352T3 (es) 2009-06-19
EP0471726B1 (de) 1997-01-08
DE122009000041I1 (de) 2009-11-05
LU91594I2 (fr) 2009-10-12
LU90204I2 (fr) 1998-04-06
LU91152I2 (fr) 2005-06-23
DE122005000017I1 (de) 2005-06-23
ATE422900T1 (de) 2009-03-15
LU91154I2 (fr) 2005-06-23
LU91592I2 (fr) 2009-10-12
EP1666057B1 (de) 2009-02-18
LU91591I2 (fr) 2009-10-12
DE69034166D1 (de) 2004-10-28
NL300403I1 (en) 2009-10-01
LU91149I2 (fr) 2005-06-23
DE122005000015I1 (de) 2005-11-24
DE122009000043I1 (de) 2009-11-05
NL300184I1 (nl) 2005-06-01
DE69029656T3 (de) 2009-06-04
EP1666057A3 (de) 2008-06-04
LU91596I2 (fr) 2009-10-12
NL300402I1 (en) 2009-10-01
DK0747058T3 (da) 2005-01-10
GB8910570D0 (en) 1989-06-21
JP2002226397A (ja) 2002-08-14
DE69034166T2 (de) 2005-08-04
ES2095874T5 (es) 2008-11-01
DE122005000016I1 (de) 2005-06-23
DE122009000042I1 (de) 2009-11-05
NL300186I1 (nl) 2005-06-01
US7479283B1 (en) 2009-01-20
JPH04505158A (ja) 1992-09-10
WO1990013313A1 (en) 1990-11-15
EP0471726B2 (de) 2008-05-14
DK0471726T3 (da) 1997-03-03
ATE276759T1 (de) 2004-10-15
LU91150I2 (fr) 2005-06-23
NL980007I1 (nl) 1998-04-01
DE122005000020I1 (de) 2005-06-23
DE122005000019I1 (de) 2005-06-23
NL300189I1 (nl) 2005-06-01
DK1666057T3 (da) 2009-06-08
LU91155I2 (fr) 2005-06-23
DE122005000014I1 (de) 2005-06-23
EP0471726A1 (de) 1992-02-26
NL300400I1 (en) 2009-10-01
ES2230555T3 (es) 2005-05-01
FR09C0033I1 (de) 2009-09-25
EP0747058A1 (de) 1996-12-11
LU91151I2 (fr) 2005-06-23
DE69029656T2 (de) 1997-04-24
DE122009000044I1 (de) 2009-11-05
NL300185I1 (nl) 2005-06-01
DE69034264D1 (de) 2009-04-02
DE69029656D1 (de) 1997-02-20
JP3281369B2 (ja) 2002-05-13
ATE147271T1 (de) 1997-01-15
LU91597I2 (fr) 2009-10-12

Similar Documents

Publication Publication Date Title
NL300183I1 (nl) Acellulair vaccin.